Yuan Yi Xie;Lu Wang;Shu Tsung Liao;Hao Yu;Ching Song
发明人:
Ching Song,Yuan Yi Xie,Lu Wang,Hao Yu,Shu Tsung Liao
申请号：
US13499864
公开号：
US20120309700A1
申请日:
2010.08.24
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Nuclear receptor LXR is an important member of 49 nuclear receptors in human bodies and has irreplaceable regulatory effects on cholesterol and fat metabolisms. The regulation of the biological activity of LXR may have therapeutic effects to the conditions such as cardiovascular and cerebrovascular obstructions, non-insulin dependent hyperglycemia, immune function disorders, and central nerve functional degeneration. We have developed a group of novel Chinese materia medica preparations targeting nuclear receptor LXR by using a computer-simulated docking technology and a process for determining biological activities of human cells cultured ex vivo. The group of preparations are featured by simple ingredients, low costs, easy to prepare, etc. No significant adverse effects were found in initial acute toxicology analysis which was carried out using mice.
